Oklahoma Medical Research Foundation scientist Sarah Ocañas, Ph.D. has become the state’s first recipient of the National Institutes of Health (NIH) Director’s Early Independence Award.
The Oklahoma City Innovation District’s 2022 Annual Breakfast will be held on November 2, beginning at 8 a.m. at the OMNI Hotel.
The Oklahoma City Innovation District will soon welcome a “once-in-a-generation” biomanufacturing workforce training center (BWTC) program to benefit all Oklahomans. One of the only programs of its kind within the United States, the BWTC program presents inclusive, non-degreed careers within the city’s emerging bioscience industry.
Chamber member, UnitedHealthcare has named Mallory Van Horn as its new CEO for the community and state health plan for Oklahoma.
The City of Oklahoma City is offering potential panhandlers A Better Way, in partnership with Mental Health Association Oklahoma, United Way of Central Oklahoma, Regional Food Bank of Oklahoma and local community members.
Greater Oklahoma City Chamber Executive Vice President Jeff Seymour was in Washington, D.C., this morning attending an invitation-only biotechnology summit at the White House. The event launched a new initiative designed to ensure America’s place in the world of biotechnology and biomanufacturing.
The San Diego Convention Center was booming with wall-to-wall activity last month as thousands of bioscience professionals converged for the 2022 Biotechnology Innovation Organization International Convention (BIO). Among them was a large contingent from Oklahoma who joined forces as part of the Oklahoma Biosciences Association (OKBio) exhibitor booth.
OU Health Stephenson Cancer Center has announced a historic first for the campus and the state: A new cancer drug, called OK-1, which was conceived and created by an OU College of Medicine researcher and developed entirely in Oklahoma, without the support of a pharmaceutical company, is being tested in humans for the first time in a Phase 1 clinical trial.
